Many years of research
and development.
Our technology is the result of 23 years of academic research, conducted at the
University Hospital of Lille by a French Inserm labelized research lab. Our mission
is to provide technologies that allow clinicians a reliable, continuous and non-invasive
evaluation of their patient’s Autonomic Nervous System activity.
MDoloris’ technologies are being refined to enhance advanced care and safety for patients and caregivers.
Physicians can trust these technologies as effective for adults and neonates and patients of all ages. Helping clinicians improve analgesia management in any clinical setting where the patients are unable to communicate is important so that our customers have the best technology available. Personalizing the administration of analgesic drugs can prevent the side effects of over/under dosages, which is vital to patients’ safety and comfort. Physicians are now able to continuously and non-invasively assess the nociception/antinociception balance of their patients and we will continue to ensure this success and drive innovation forward.
Videos
MDoloris Medical Systems presents ANI (Analgesia Nociception Index) technology

Masimo & MDoloris: ANI MOC-9
To better determine treatment options for our patients, we collaborated with Masimo, one of the biggest global medical technologies companies in the world, to bring you the development of the ANI MOC-9, a module with ANI (Analgesia Nociception Index) technology integrated into Masimo’s ROOT monitor platform. The use of ANI technology allows clinicians to monitor the balance between analgesia and nociception measuring the Autonomic Nervous System and determine treatment options for patients.
Read the press release HERE !
Keep in touch with our latest news

Testimonials
OOur technologies are used by top physicians around the world in both OR and ICU settings